Zobrazeno 1 - 10
of 4 508
pro vyhledávání: '"Alloimmunization"'
Autor:
Sanae Ouadghiri, Kaoutar El Morabit, Naoual Elansari, Ouafae Atouf, Maria Elkababri, Laila Hessissen, Malika Essakalli
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 360-365 (2024)
Introduction: Beta-thalassemia major patients need a regular blood transfusion to have an initial normal growth. However, these patients have an increased risk of developing alloantibodies. Our main goal was to study HLA alloimmunization in Moroccan
Externí odkaz:
https://doaj.org/article/d0680803f62e4f3b8b95ce0655069cc5
Autor:
Sangeeta Pahuja, Piali Mandal
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 9, Iss 3, Pp 200-206 (2024)
Blood transfusion is the mainstay for management of hemoglobinopathies, including thalassemia and sickle cell disease (SCD). Apart from other transfusion related adverse effects, immunization is a significant complication, particularly in multitransf
Externí odkaz:
https://doaj.org/article/6fe0d116b52f43959b2dc30fbc5f202d
Autor:
Larissa Espíndola Leite, Fábio Gonçalves da Silva, Simone Kashima, Evandra Strazza Rodrigues, Rodrigo Haddad
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 3, Pp 261-267 (2024)
Introduction: Sickle cell disease (SCD) is the most important hemoglobinopathy worldwide. The treatment often requires phenotype-matched red blood cell (RBC) transfusions, but alloimmunization to non-ABO antigens may occur in a part of the SCD patien
Externí odkaz:
https://doaj.org/article/2946b66740f94818a3bfd623c2f995af
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S246-S257 (2024)
Background: Hemolytic disease of the fetus and newborn is a public health problem caused by maternal-fetal incompatibility; no prophylaxis is available for most alloantibodies that induce this disease. This study reviews the literature regarding whic
Externí odkaz:
https://doaj.org/article/901e88bc4bac4daebd7f4cea6ba8baff
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S97-S102 (2024)
Background and Objectives: The identification of platelet antibodies is essential for diagnosing and managing conditions such as fetal and neonatal alloimmune thrombocytopenic purpura, post-transfusion purpura, and immune platelet refractoriness. Mon
Externí odkaz:
https://doaj.org/article/d6f919171d99439ba07c10b10623f537
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Exposure to allogenic red blood cells (RBCs), either through pregnancy or transfusion, can result in alloimmunization, which can lead to severe hemolytic transfusion reactions and pregnancy complications. Passively administered antibodies can be used
Externí odkaz:
https://doaj.org/article/ecfcb5aecbad4b98ad4adc86019b6077
Autor:
Radoslaw Ciesielski, Anna Mich, Klaudia Perkowska, Anna Kaźmierczak, Wiktoria Izdebska, Patrycja Sornek, Anna Kiełb, Igor Pawlak, Jakub Stanek, Agata Borkowska
Publikováno v:
Quality in Sport, Vol 32 (2024)
Introduction: The success in preventing and treating Rh D alloimmunization is a major accomplishment in modern obstetrics. The widespread use of Rh D immune globulin has led to a decline in red cell alloimmunization. Despite evidence of its effect
Externí odkaz:
https://doaj.org/article/0787a43574444a5b876057b499b0c534
Publikováno v:
Journal of Obstetric Anaesthesia and Critical Care, Vol 14, Iss 2, Pp 170-172 (2024)
Gestational thrombocytopenia, preeclampsia, and immune thrombocytopenia are commonly recognized etiologies of low platelet counts representing the vast majority of encountered gestational cases (86-100%). However, there are many other rare causes. Th
Externí odkaz:
https://doaj.org/article/75f2679c47d04522b0edf90878a22838
Publikováno v:
Journal of Applied Hematology, Vol 15, Iss 2, Pp 121-129 (2024)
BACKGROUND: Alloantibodies against donor red blood cells (RBCs) are developed by patients with transfusion-dependent thalassemia (TDT), which causes the donor RBCs to hemolyze. This decreases the transfusion’s efficacy and increases the risk of adv
Externí odkaz:
https://doaj.org/article/70ca61b9c53347c3a7338924465bdc60
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 6, Pp 2507-2510 (2024)
Maternal isoimmunization occurs when a pregnant woman develops an immune reaction due to the inheritance of a red-cell antigen, which is paternally derived and can result in fetal anemia, hemolysis, fetal death, and hydrops fetalis as the antibodies
Externí odkaz:
https://doaj.org/article/e73f3d34786a437c994bce999b953642